Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,059 | -1,482 | -1,674 | -1,237 | -5,467 |
| Depreciation Amortization | 54 | 40 | 27 | 13 | 54 |
| Other Working Capital | 29 | -39 | 74 | 426 | -698 |
| Other Operating Activity | 616 | 468 | 367 | 194 | 903 |
| Operating Cash Flow | $-1,360 | $-1,014 | $-1,206 | $-604 | $-5,209 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | N/A | N/A | 188 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | 617 |
| Other Financing Activity | 596 | 610 | 635 | 645 | 819 |
| Financing Cash Flow | $596 | $610 | $635 | $645 | $1,624 |
| Exchange Rate Effect | 9 | -4 | -33 | -31 | -34 |
| Beginning Cash Position | 4,959 | 4,931 | 5,002 | 4,956 | 8,622 |
| End Cash Position | 4,204 | 4,523 | 4,398 | 4,966 | 5,004 |
| Net Cash Flow | $-755 | $-408 | $-605 | $10 | $-3,619 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,360 | -1,014 | -1,206 | -604 | -5,209 |
| Free Cash Flow | -1,360 | -1,014 | -1,206 | -604 | -5,209 |